Scoop has an Ethical Paywall
Licence needed for work use Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

“Grants4Apps® Accelerator” Program 2016

Bayer “Grants4Apps® Accelerator” Program 2016

Looking for New Zealand health technology innovations

Bayer New Zealand Ltd is inviting health technology start-up companies looking for support to bring their innovation to market to apply to the company’s “Grants4Apps® Accelerator” program.

“Grants4Apps” is an open innovation initiative, launched in 2013 as a crowdsourcing program. It provides financial support to developers and startups for their software, hardware and technology projects which contribute to improve health outcomes or pharmaceutical processes.

The crowdsourcing program was expanded with the Accelerator as a new model of open innovation in the digital health field in 2014.

The “Grants4Apps Accelerator” offers dedicated office space for five digital health startups with concepts for innovative technology solutions to healthcare problems at the headquarters of the company’s Pharmaceutical Division in Berlin to support them in further advancing their projects and business models.

Each startup receives up to 50,000 Euro (roughly $80,000 NZD) as financial support and can stay in the “Grants4Apps Accelerator” premises for about 100 days. During that time, Bayer offers experienced managers as coaches to the startups, in addition to intensive mentoring by external entrepreneurs. Thereby, the Accelerator creates an ideal environment in which to advance cutting-edge technologies in healthcare and underlines Bayer’s engagement in collaboration with young entrepreneurs.

Advertisement - scroll to continue reading

“Innovation is what drives Bayer and we are keen to support others in developing initiatives that can make a real difference to the lives of doctors and patients,” said Suzanne Subritzky, Bayer New Zealand Pharmaceuticals Commercial Lead.

“Bayer recognises the creative potential outside the company and believes that combining expertise is key to innovation and success.

“Complementing our own capabilities by establishing relationships with excellent partners from science and industry is an essential element of our strategy and one that adds great value at all levels and phases of our business.

“The Grants4Apps Accelerator creates an ideal environment to foster digital innovation in healthcare and is an excellent example of our engagement in open innovation.”

The Grants4Apps program is particularly looking for any integrated next-generation technology that supports patient adherence, diagnosis, therapy management or prevention.

Special consideration will be given to applicants involved in:

• Patient-doctor feedback in the area of women’s health

• Patient engagement in cardiology, oncology, radiology and ophthalmology.

The application process is now open and closes on May 31st, 2016.

» Read more or submit your proposal on the Grants4Apps website

ENDS

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.